PMDA inspection

AstraZeneca Pharmaceuticals LP

PMDA inspection 5130608035588 · USA · Suitable

Key facts

Control number 5130608035588
Manufacturing site AstraZeneca Pharmaceuticals LP
Location 587 Old Baltimore Pike Newark DE 19702 United States of America
Country USA
Product type Pharmaceuticals
Application type Regular
Inspection method Remote
Inspection month Nov 1, 2024
Result Suitable
Result notified Nov 14, 2024
PMDA registration AG30400527

About PMDA GMP inspections (Japan)

Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Browse all PMDA GMP inspections (Japan)